BioLineRx Ltd (BLRX)

[midastouch017]

6 Analysts Bullish Bioline RX Ltd (BLRX)
August 17, 2017 - By Linda Rogers

https://kgazette.com/triple-frond-partners-lowered-visa-v-holding-6-analysts-bullish-bioline-rx-ltd-blrx/

Among 6 analysts covering BioLineRx (NASDAQ:BLRX), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. BioLineRx had 13 analyst reports since July 27, 2015 according to SRatingsIntel.
Maxim Group maintained the shares of BLRX in report on Monday, July 10 with “Buy” rating.
On Thursday, May 18 the stock rating was upgraded by Maxim Group to “Buy”. The stock of Bioline RX Ltd (NASDAQ:BLRX) has “Buy” rating given on Wednesday, August 9 by H.C. Wainwright.
The rating was maintained by Oppenheimer on Tuesday, August 8 with “Buy”. H.C. Wainwright maintained Bioline RX Ltd (NASDAQ:BLRX) rating on Friday, June 2. H.C. Wainwright has “Buy” rating and $4.00 target. The firm earned “Buy” rating on Friday, May 26 by H.C. Wainwright. The firm has “Buy” rating given on Thursday, June 1 by Maxim Group. The company was maintained on Tuesday, August 8 by Maxim Group. The rating was initiated by Roth Capital with “Buy” on Thursday, August 3. The firm earned “Hold” rating on Friday, August 12 by Maxim Group. See Bioline RX Ltd (NASDAQ:BLRX) latest ratings:

08/08/2017 Broker: Oppenheimer Rating: Buy New Target: $3.0000 Maintain
09/08/2017 Broker: H.C. Wainwright Rating: Buy New Target: $4.0000 Maintain
08/08/2017 Broker: Maxim Group Rating: Buy New Target: $3.0000 Maintain
04/08/2017 Broker: Oppenheimer Rating: Outperform New Target: $3 Initiates Coverage On
03/08/2017 Broker: Roth Capital Rating: Buy New Target: $3.0000 Initiate
10/07/2017 Broker: Maxim Group Rating: Buy New Target: $3.0000 Maintain
02/06/2017 Broker: H.C. Wainwright Rating: Buy New Target: $4.0000 Maintain
01/06/2017 Broker: Maxim Group Rating: Buy New Target: $3.0000 Maintain
26/05/2017 Broker: H.C. Wainwright Rating: Buy New Target: $4.0000 Maintain
18/05/2017 Broker: Maxim Group Old Rating: Hold New Rating: Buy Upgrade